Skip to main content
Substance P peptide vial

Substance P

Substance P is an 11-amino acid neuropeptide involved in pain transmission, inflammation, and various neurological processes. While not used therapeutically itself, understanding it is crucial for pain research.

Mechanism of Action

Binds primarily to NK1 receptors to transmit pain signals from peripheral nerves to the CNS. Also promotes inflammation, causes vasodilation, and stimulates immune cells.

Dosage Overview

Dose Range

35 mcg – 350 mcg

Route

subcutaneous

Frequency

1x daily

Cycle Length

1 weeks

Reconstitution

Vial: 5 mgBAC Water: 2.0 mlConcentration: 2,500 mcg/ml

Typical Dosage (Research)

Not used as a therapeutic agent. NK1 receptor antagonists (blocking Substance P) are used clinically for chemotherapy-induced nausea.

Research compound only. Therapeutic applications focus on blocking rather than administering Substance P.

Considerations for Men & Women

Women: Neuropeptide involved in pain signaling and inflammation. Women generally have higher substance P levels and may be more sensitive to its effects. Research doses are weight-based, so absolute doses differ. Relevant to fibromyalgia research, which disproportionately affects women.

Men: Lower baseline substance P levels. Same weight-based research dosing. Acute use only — not a chronic therapy.

Individual responses vary. These notes reflect general trends from research literature and are not medical advice.

Quick Calculator

Concentration: 2.5 mg/ml

Volume to inject: 0.01 ml

Syringe units (U-100): 1.4 units

Pre-filled with Substance P defaults. Adjust values as needed.

Open Full Calculator →

Side Effects & Risks

Administration would cause pain, inflammation, and neurogenic responses. Not given therapeutically.

Exogenous administration would be harmful. Research focuses on antagonists not agonists.

Who Uses Substance P

Pain researchers, neuroscientists studying nociception, those researching neurogenic inflammation.

Adamax1 shared

Adamax is a modified version of Semax with an adamantane group attached, designed to enhance its nootropic effects and extend duration of action compared to standard Semax.

Cognitive Performance
Compare with Substance P
FGL1 shared

FGL (FG Loop) is a synthetic peptide that mimics the neural cell adhesion molecule (NCAM) FG loop region. It promotes neuroplasticity and has shown cognitive-enhancing effects in research.

Cognitive Performance
Compare with Substance P
PE-22-281 shared

PE-22-28 is a synthetic peptide fragment derived from research on the SAMP8 mouse model of accelerated aging. It has shown potential for enhancing memory and reducing cognitive decline.

Cognitive Performance
Compare with Substance P
NAD+1 shared

Nicotinamide Adenine Dinucleotide (NAD+) is an essential coenzyme found in every living cell. It plays a central role in energy metabolism, DNA repair, gene expression, and cellular signaling. NAD+ levels naturally decline with age, and restoring them has become a major focus of longevity research. Injectable NAD+ bypasses the GI tract for higher bioavailability compared to oral precursors like NMN or NR.

Cognitive Performance
Compare with Substance P
Cortexin1 shared

Cortexin is a polypeptide complex derived from pig brain cortex, used clinically in Russia and Eastern Europe for neurological conditions including stroke recovery, traumatic brain injury, and cognitive decline.

Cognitive Performance
Compare with Substance P